spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

PCI Clinical Services Announces Launch of FastTrackTM Service that Enables Rapid Delivery of Investigational Products to Patients

PCI Pharma Services

Philadelphia, USA – 7 August 2017

         
   Leading pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has today announced the launch of its expedited Clinical packaging, labeling and distribution service FastTrackTM. The system delivers Clinical Trial supplies for time critical studies in the shortest possible turnaround.

Developed in advance of packaging and operations and maintaining rigorous cGMP standards, PCI’s FastTrackTM service has individual operating procedures and workflows to significantly streamline processes. Utilizing in-house label printing capability, FastTrackTM can complete label design, printing, receipt and Qualified Person (QP) release within 10 days thanks to a dedicated and specialized team, significantly reducing turnaround time for investigational study supplies and reducing the risk of patient impact due to supply shortage.

For study drug resupply, PCI can also complete repeat packing runs and QP release in just three days, including label printing, using its dedicated ‘FastTrackTM: On Demand’ service, allowing flexibility of bulk drug material so it can be used across multiple studies and labelled for a number of countries. Another expedited solution is ‘FastTrackTM: Just in Time’, which offers sponsor companies increased supply flexibility by the application of a protocol or expiry date label at the point of dispatch within just two days. The Just in Time solution also provides for supply chain strategies such as pooled drug supplies across multiple protocols and a solution to any challenges posed by updates to Annex VI, the regulatory classification system for the labeling and packaging of Clinical products.
 
Commenting on FastTrack, Samantha James, Associate Director, Clinical Operations at PCI Clinical Services, said: “PCI is committed to developing innovative solutions to support our client’s requirements. We have established these new processes with a focus of reducing waste and reducing cost to the client, removing the need to rework supplies when managing multiple protocols. It is an exciting time for PCI with the launch of FastTrack which will increase the flexibility and efficiency of our service whilst maintaining our high-quality standards.”

“We are always looking at ways to make our client’s lives easier. Introducing FastTrackTM means that we can offer them the ability to supply Clinical sites with fully packaged and released materials in a matter of days. With our dedicated FastTrackTM team, we can offer this service without any compromise to the high-quality standards to which we adhere, and will liaise closely with the client to ensure that their time targets are met.”

Complicated study protocols, demanding deadlines and distribution to remote global destinations can create challenges for delivery and PCI is committed to facilitating the introduction of solutions such as FastTrackTM to provide customers with the services they need.

Now more than ever, timely and efficient delivery of IMPs is considered crucial to the execution of global Clinical Trials. As part of the FastTrackTM service, PCI has appointed a team of highly skilled, dedicated and cross functional staff to conduct multiple tasks efficiently, aligned with QPs at every touchpoint, to ensure the fast and seamless delivery of IMPs to patients in this breakthrough methodology.

About PCI


The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over four decades in the healthcare business. Leading technology and continued investment enables us to address global development needs throughout the product life cycle — from Phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives. For more information, please visit www.pciservices.comor follow us on Twitter at @PCI_Social.

Contact

Chantel Richman / Carrie Lowe at Remarkable Content

chantel.richman@remarkablegroup.co.uk / carrie.lowe@remarkablegroup.co.uk

T: +44 (0) 1962 893 853 / 913
phone +44 (0)1495 713 633
email sales@pciservices.com
web www.pciservices.com
email Wye Valley Business Park, Hay-on-Wye, HR3 5PG
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Denny Bros Group continues its support of Packaging Innovations

A world leading print company is preparing to showcase its renowned labelling and printing solutions at next month’s prestigious Packaging Innovations show.
More info >>


White Papers

Shipping with Active Packaging Containers: Three Pre-flight Decisions that Impact the Success of High-value Global Shipments

World Courier

It is the dead of winter in the northern hemisphere and the height of summer in the southern, with external temperature fluctuations exceeding 50 degrees. Flight delays have added precious days to the transport of your multi-million dollar shipment of blockbuster drug from South East Asia destined for Russia. In France, the roads are closed for days due to a monster snowstorm, with your irreplaceable shipment of investigational drugs stopped somewhere en route between Paris and the clinical trial site. Will all be lost, or can informed choices made before the shipment departs ensure product safety despite unforeseen circumstances?
More info >>

Industry Events

3D Cell Culture 2018

21-22 February 2018, Holiday Inn Kensington Forum, London UK

Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement